NeuroScientific Biopharmaceuticals Secures $3.7m tax incentive refund
NeuroScientific Biopharmaceuticals (NSB) pockets a $3.7 million tax refund from the Australian...
NeuroScientific Biopharmaceuticals Appoints Paul Rennie as interim CEO
NeuroScientific Biopharmaceuticals (NSB) appoints Paul Rennie as interim CEO, nearly three...